Related by context. All words. (Click for frequent words.) 54 Roger Perlmutter Amgen 53 Janet Woodcock MD 52 Steven Galson MD MPH 51 Dr. Zincke 51 Nicole Onetto MD 51 Steven Galson MD 51 Paolo Paoletti MD 50 Richard Pazdur 50 Alessandro Riva 50 anti angiogenic therapy 50 Kemal Malik 49 curative therapy 49 Surgical resection 49 Daniel Junius 49 TTF Therapy 48 Pedro Lichtinger 48 Dr. Mace Rothenberg 48 Lilly Alimta 48 Kattlove 48 Karel Reisz suffered 47 BRAF inhibitors 47 Patricia Hartge 47 postoperative radiotherapy 47 Elizabeth G. Nabel 47 TroVax ® 47 ELACYT 47 relapsed SCLC 47 Allovectin 7 ® 47 Debasish Roychowdhury MD 47 Kirk Garratt 47 neoadjuvant therapy 47 Mark HN Corrigan 47 Richard Pazdur MD 46 Eric Winer 46 drug Treanda 46 H. Kirn 46 Patricia O'Looney 46 Hal Barron 46 Mace Rothenberg 46 treating neuropathic pain 46 Dino Dina 46 Lisa N. Drakeman 46 chemoradiation therapy 46 Kidney transplantation 46 John E. Niederhuber 46 mutated BRAF gene 46 Avastin Tarceva 46 Orville G. Kolterman 46 temsirolimus 46 Jeffrey Shuren 46 Cristofanilli 45 percutaneous cryoablation 45 Bresalier 45 Provecta 45 Eliezer Zomer Ph.D. 45 adjuvant therapies 45 Oncotype 45 AstraZeneca Iressa 45 Lorianne Masuoka MD 45 PNH patients 45 Advaxis Phase 45 tumor histology 45 oncologic 45 Steven Galson acting 45 adjuvant radiotherapy 45 preoperative chemotherapy 45 Adjuvant chemotherapy 45 Roxana Mehran MD 45 Kieran Breen 45 curative treatments 45 Dr. Richard Pazdur 44 Troxatyl 44 gemcitabine chemotherapy 44 postoperative chemotherapy 44 Donna Ambrosino 44 figitumumab 44 refractory angina 44 Iris Loew Friedrich 44 Dr. Francesco Rubino 44 Jorge Cortes MD 44 chemoradiotherapy 44 systemic mastocytosis 44 commercialize deforolimus 44 overlapping toxicities 44 Kathy Giusti Founder 44 Tectin TM 44 samalizumab 44 Roche Herceptin 44 hematologic malignancy 44 Dr. Frank Vocci 44 Camillo Ricordi MD 44 Paolo Paoletti 44 Hepatocellular Carcinoma HCC 44 Brian JG Pereira 44 skeletal metastases 44 triphendiol 44 Dr. Wolfgang Wein 44 Howard Fillit MD 44 ADVEXIN therapy 44 prognostic biomarkers 44 Sandra Kweder 44 Seewaldt 44 renal carcinoma 44 vandetanib 44 standard chemotherapy regimens 44 Vicki Pontius 43 motesanib 43 Clot busting 43 irinotecan chemotherapy 43 Dr. Feczko 43 colorectal lung 43 spontaneous regression 43 prescribe statins 43 Cancer Immunobiology Center 43 FDA Deborah Autor 43 liver metastasis 43 AML acute myeloid 43 Steven Galson 43 Kauffman MD Ph.D. 43 palliative radiotherapy 43 pharmacologic therapies 43 diagnostic modality 43 vascular anatomy 43 oral clodronate 43 Amgen Vectibix 43 curability 43 Dr. Bernhard Kirschbaum 43 Richard Schilsky 43 Evoltra TM 43 BRAF V# mutation 43 IRX 2 43 erlotinib Tarceva 43 Norbert Bischofberger PhD 43 metastatic lung cancer 43 Teverelix 43 gastro intestinal stromal tumors 43 sorafenib Nexavar 43 Intravenous CP 43 Samuel Z. Goldhaber 43 pharmacologic intervention 43 recurrent glioblastoma 43 Oliver Sartor 43 osteoporotic compression fractures 43 Bruce Kuhlik 43 TYSABRI natalizumab 43 nonsquamous 43 androgen ablation 42 non resectable liver 42 EGFR mutation status 42 SUTENT ® 42 Li Fraumeni Syndrome 42 Vandetanib 42 treating cancerous tumors 42 transplantation HCT 42 metastatic kidney 42 Yvonne Greenstreet 42 cranial radiation 42 Aggrastat ® tirofiban hydrochloride 42 Michael H. Tardugno 42 paclitaxel poliglumex 42 Geno Germano 42 Pixantrone 42 metastatic uveal melanoma 42 uncontrolled epilepsy 42 pazopanib 42 sentinel lymph node biopsy 42 June Almenoff MD 42 Fibrillex 42 Vojo Vukovic MD Ph.D. 42 thymectomy 42 Fibrillex TM 42 metastatic renal cell 42 Triptans 42 antimicrobial prophylaxis 42 prolongs survival 42 Edwin Hemwall 42 Elizabeth Battaglino Cahill 42 postoperative mortality 42 seminoma 42 relapsed ovarian cancer 42 CTEPH 42 metastatic gastric 42 recurrent metastatic 42 M. Perlmutter 42 anti angiogenic agents 42 Cheson 42 medically inoperable 42 LE DT 42 KRAS status 42 Eric K. Rowinsky 42 Jesse Blout San Francisco 42 Gleevec imatinib 42 resectable 42 Trevor Mundel MD 42 HER2 positive cancers 42 OSUCCC James 42 chemotherapeutic regimens 42 inoperable pancreatic cancer 42 prognostic indicator 42 hematological disorders 42 Golfer Ballesteros 42 lymph node removal 41 Beall Ph.D. 41 pain palliation 41 prophylactic cranial irradiation 41 palliation 41 Dr. Herman Kattlove 41 Evoltra ® 41 chemoembolization 41 elacytarabine 41 Alimta pemetrexed 41 oncological outcomes 41 squamous non 41 Chemophase 41 cytoreduction 41 lymphoma leukemia 41 Glioblastoma Multiforme GBM 41 clinically localized prostate 41 intra arterial chemotherapy 41 alveolar rhabdomyosarcoma 41 Kinase inhibitors 41 ZOLINZA 41 Leonard Saltz 41 Stephen Huhn 41 pertuzumab 41 Dr. Vitetta 41 Paolo Pucci chief 41 cardiac revascularization 41 Breast Oncology 41 aromatase inhibitors AIs 41 Belldegrun 41 chemotherapy hormonal therapy 41 SNT MC# 41 poststroke depression 41 intraperitoneal therapy 41 antiangiogenic agents 41 Neuro Oncology Program 41 cytotoxic therapy 41 chemoradiation 41 antibiotic prophylaxis 41 GVAX Pancreas Vaccine 41 radiation therapy SBRT 41 Acute Myeloid Leukaemia AML 41 Inhaled insulin 41 lenalidomide dexamethasone 41 acute lymphoblastic 41 locoregional recurrence 41 pancreatic adenocarcinoma 41 surgically resectable 41 Bioaccelerate compounds under 41 Anthony Fauci 41 Torisel 41 thromboembolic disease 41 neoadjuvant treatment 41 recurrent glioblastoma multiforme 41 MMP inhibitors 41 immune suppressing medication 41 refractory acute myeloid 41 differentiated thyroid 41 relapsed leukemia 41 cancerous polyp 41 rhabdoid 41 invasive biopsy 41 cirrhosis liver failure 41 Panzem 41 Oral corticosteroids 41 adjuvant therapy 41 testosterone supplementation 41 Len Lichtenfeld MD 41 GIST tumors 41 methotrexate therapy 41 oxymorphone ER 41 colorectal cancer liver metastases 41 taxane refractory 41 hoFH patients 41 IVIG therapy 40 Liver transplantation 40 refractory metastatic 40 Radical prostatectomy 40 antithrombotic therapy 40 localized renal 40 bowel resection 40 curable cancers 40 TNF blocker therapy 40 curative therapies 40 metastatic sarcomas 40 HER2 positive metastatic breast 40 SIADH 40 tumor subtype 40 KRAS mutation 40 potentially hepatotoxic 40 thetreatment 40 impair fertility 40 ovarian malignancy 40 thyroid nodules 40 5-fluorouracil/leucovorin 40 Perforomist ™ Inhalation Solution 40 pharmacological intervention 40 patients undergoing chemotherapy 40 biliary tract cancer 40 Sudhir Agrawal D.Phil 40 chemotherapy radiotherapy 40 Coronary artery bypass 40 immunosuppressive regimens 40 prognostic variables 40 Lung transplantation 40 periprosthetic infection 40 Adjuvant therapy 40 advanced hepatocellular carcinoma 40 pre operatively 40 cytoreductive surgery 40 dopaminergic therapy 40 hormonally responsive 40 therapeutic armamentarium 40 metastatic cancers 40 malignant pleural mesothelioma 40 LEE Jong wook 40 Dr. Andreas Barner 40 axitinib 40 metastatic bladder 40 histologic diagnosis 40 hematological malignancy 40 antiangiogenic drugs 40 Related Anemia 40 BZL# 40 anticancer therapy 40 Vidaza azacitidine 40 thalidomide Thalomid 40 therapeutic regimens 40 Rachel Ballard Barbash 40 ICD therapy 40 malignant growths 40 peritoneal cancer 40 stage IIIA 40 Avastin Erbitux 40 EGFR mutation positive 40 bone marrow biopsies 40 intracranial stenosis 40 PROLARIS 40 androgen deprivation 40 percutaneous biopsy 40 ferroportin levels 40 Rich Dietman 40 debulking surgery 40 gastrointestinal stromal tumors 40 angiogenesis inhibition 40 NSCL cancer 40 herceptin 40 dalbavancin 40 ganetespib 40 refractory colorectal cancer 40 metastatic colorectal 40 endocrine therapies 40 ovarian suppression 40 subclinical disease 40 Abiraterone acetate 40 cytotoxic chemotherapy 40 gastrointestinal stromal tumor GIST 40 Nerve stimulation 40 fulvestrant 40 conformal radiotherapy 40 Hydroxyurea 40 Di Bisceglie 40 nonsmall cell lung cancer 40 metastatic liver 40 symptomatic aortic stenosis 40 Gefitinib 40 IMC #B 39 efficacious treatments 39 HER2 positive breast 39 stage IIIB IV 39 cabazitaxel 39 DCVax R 39 perioperative morbidity 39 squamous cell lung cancer 39 TEMODAL 39 tumor resection 39 Chronic lymphocytic leukemia 39 concurrent chemoradiation 39 Riluzole 39 Dr. Gideon Koren 39 metastatic bone 39 Cell Lymphoma CTCL 39 Nothing Wadden 39 allogeneic HSCT 39 thymic carcinoma 39 TNFerade TM 39 chemo therapy 39 Hurthle cell 39 ovarian lung 39 myelination disorders 39 nephron sparing surgery 39 prognosis 39 Daniel Rotrosen MD 39 prognostic indicators 39 Anthony S. Fauci 39 myelogenous leukemia 39 hematological toxicity 39 Carcinoid Syndrome 39 preoperative staging 39 malabsorptive 39 Rituxan rituximab 39 AN Safaya 39 stricken Lockerbie bomber 39 antireflux surgery 39 Jean Jacques Bienaime 39 talactoferrin 39 decompensated cirrhosis 39 TransVax 39 non squamous 39 pharmacological treatments 39 Accelerated Partial Breast Irradiation 39 malignant pheochromocytoma 39 urinary blockage 39 immunosuppressive medication 39 Alfred I. Neugut 39 advanced HER2 positive 39 preventing recurrences 39 smoldering multiple myeloma 39 forodesine 39 adverse cytogenetics 39 Gleevec Glivec 39 DACH platinum 39 diagnosis 39 oral anticoagulant therapy 39 Ceplene/IL-2 39 liver transplantation 39 MabThera Rituxan 39 FOLFOX chemotherapy 39 postoperative complication 39 pancreatic islet cell 39 cardiotoxicity 39 myelofibrosis 39 Alan Silman 39 R0 resection 39 underlying pathophysiology 39 Dr. Barbara Alving 39 indolent lymphomas 39 Cojocaru correspondent 39 cisplatin chemotherapy 39 adjuvant chemotherapy 39 postsurgical 39 prostate cancer CRPC 39 metastatic ovarian cancer 39 polyomavirus nephropathy 39 invasive lobular carcinoma 39 Certolizumab pegol 39 ocular inflammatory 39 chronic angina 39 Archexin 39 Joseph Zabramski 39 neoadjuvant setting 39 undergoing hysterectomy 39 grade serous ovarian 39 haematological cancers 39 treat enlarged prostate 39 blood clot dissolving 39 preoperative diagnosis 38 axillary dissection 38 CINTREDEKIN BESUDOTOX 38 chemotherapies 38 malignant lymphomas 38 lymphomas leukemias 38 surgical debulking 38 MYCN amplification 38 pancreatic ductal 38 refractory Hodgkin 38 antirejection 38 defibrillator implant 38 Mitoxantrone 38 ependymoma 38 allogenic stem cell 38 diagnose Alzheimer disease 38 sentinel node biopsy 38 vaccine Fauci 38 oral anticancer 38 Dr. Debra Birnkrant 38 Nora D. Volkow 38 cranial irradiation 38 relapsed ALL 38 Akshay Vaishnaw MD Ph.D. 38 uncontrolled asthma 38 Dr. Steven Galson 38 immunosuppressive therapies 38 precancerous colon growths 38 FROVA 38 Lymph node 38 hematological diseases 38 Glivec imatinib 38 vascular anomalies 38 nonpharmacologic 38 Temodar ® 38 SLN biopsy 38 taxane chemotherapy 38 radiographic outcomes 38 Jevtana 38 malignant brain 38 Metastatic colorectal cancer 38 heterozygous FH 38 Malignant glioma 38 atypical rhabdoid tumor 38 Atul Pande MD 38 leukemia myeloma 38 Chronic pancreatitis 38 hepatorenal syndrome 38 pelvic lymphadenectomy 38 Dr. Joan Duwve 38 thrombo embolic 38 Lilly Gemzar 38 pharmacological therapy 38 idiopathic pulmonary fibrosis IPF 38 BRCA mutation carriers 38 Golimumab 38 Relapsing remitting MS 38 metastatic colon cancer 38 hyperphosphataemia 38 chronic leukemias 38 GnRH agonists 38 congenital fibrinogen deficiency 38 uterine myoma 38 undergoing chemo 38 IV NSCLC 38 hormone refractory 38 radiotherapy chemotherapy 38 FDG PET 38 colorectal ovarian 38 neuroendocrine cancers 38 thrombotic complications 38 esophagectomy 38 Garcia Manero 38 novel immunotherapies 38 perioperatively 38 Inhaled nitric oxide 38 HERCEPTIN 38 Hassenbusch 38 anaplastic 38 Everolimus 38 macroglobulinemia 38 Dr Peter Piot 38 radical cystectomy 38 CMV infections 38 MGN# 38 neoadjuvant chemoradiotherapy 38 Gene Saragnese 38 stent thrombosis blood clots 38 hormone receptor status 38 osteoarthritic pain 38 Bone marrow transplant 38 durable remissions 38 monoclonal gammopathy 38 TNM staging 38 OnDose TM 38 Heavy menstrual bleeding 38 locoregional 38 chromosomal mutations 38 bile duct cancers 38 investigational therapies 37 nonmyeloablative 37 adjuvant systemic 37 colorectal liver metastases 37 recurrent ischemic stroke 37 advanced epithelial ovarian 37 myelodysplastic syndromes 37 cyclophosphamide chemotherapy 37 preventive mastectomy 37 AVASTIN 37 aetiology 37 ORENCIA R 37 Hormone pills 37 pancreatic lung 37 undergo radical prostatectomy 37 HER2 positive breast cancer 37 de novo kidney transplant 37 Kenneth Olden 37 operable breast cancer 37 treatment 37 recurrent glioblastoma multiforme GBM 37 curative resection 37 precursor lesions 37 HER2 positive 37 therapies 37 pemphigus vulgaris 37 brain metastases 37 Smac mimetic 37 LPLD 37 mismatched bone marrow 37 lung biopsy 37 Glioblastoma Multiforme 37 ablative therapy 37 radiation chemoradiation 37 standard chemotherapy regimen 37 hematopoietic malignancies 37 treating sarcoma testicular 37 erlotinib Tarceva ® 37 antiplatelet therapies 37 Anthracycline 37 BRCA carriers 37 obatoclax 37 receiving chemoradiation therapy 37 thoracoscopic lobectomy 37 Campos Outcalt 37 corticosteroid therapy 37 oncologic outcomes 37 Venous thromboembolism 37 uterine fibroid 37 glioblastoma 37 postoperative pulmonary 37 BANZEL 37 aldosterone antagonists 37 YONDELIS 37 Kevin De Cock 37 abiraterone 37 anthracyclines taxanes 37 Watchful waiting 37 metastatic dermatofibrosarcoma protuberans DFSP 37 antiinflammatory drugs 37 CT angiogram 37 Bevacizumab Avastin 37 docetaxel Taxotere ® 37 immunotherapeutic approaches 37 minimally symptomatic 37 immune modulating 37 Lisofylline 37 CCR9 antagonist 37 FGFR2 gene 37 nerve decompression 37 ZACTIMA TM ZD# 37 cystectomy 37 CMV disease 37 tanespimycin 37 resistant hormone refractory 37 angiogenic therapy 37 chemo radiotherapy 37 pemetrexed Alimta 37 IDH mutations 37 hypervascular tumors 37 myeloproliferative disorder 37 Graft Versus Host 37 allergen immunotherapy 37 doublet chemotherapy 37 androgen ablation therapy 37 multiple sclerosis psoriasis 37 renal tumors 37 microwave hyperthermia 37 sickest colon cancer 37 prostate carcinoma 37 heavily pretreated 37 molecularly targeted therapies 37 neoadjuvant chemotherapy 37 Susan B. Shurin 37 monoclonal antibody therapies 37 carcinoid 37 pancreatic cyst 37 myeloproliferative disease 37 Hormonal therapy 37 cardiotoxic 37 antiarrhythmic medications 36 incidentalomas 36 glucocorticoid therapy 36 opioid tolerant adult 36 leukemia multiple myeloma 36 Novartis Gleevec 36 precancerous condition 36 pilocytic astrocytomas 36 Acute leukemia 36 interferon therapy 36 Eisenmenger syndrome 36 prognostic marker 36 indolent NHL 36 Acute Radiation Syndrome ARS 36 VIDAZA ® 36 PITX2 methylation 36 androgen suppression therapy 36 contralateral breast 36 nonoperative treatment 36 oxaliplatin Eloxatin 36 malignant salivary gland 36 secretory diarrhea 36 aromatase inhibitor therapy 36 recurrent NSCLC 36 Dr Rasiah 36 anidulafungin 36 mTOR kinase 36 multiorgan 36 spinal metastases 36 Stent thrombosis 36 Noxafil 36 extrapleural pneumonectomy 36 Squamous cell 36 Surgical excision 36 relapsed AML 36 anticancer therapies 36 cystic lesions 36 atrial arrhythmias 36 GISTs 36 neurological complications 36 zileuton IV 36 immunodeficiency disorders 36 urothelial cancer 36 bone metastases 36 lumbar disk herniation 36 unresectable tumors 36 Mucositis 36 Bioenvision compounds under 36 glioblastoma brain tumor 36 HNSCC 36 Bezielle 36 Non Hodgkins lymphoma 36 plasminogen activators 36 OMNARIS HFA 36 Bob Evani 36 Dr. Karen Midthun 36 inhaled bronchodilators 36 kidney urologic 36 localized prostate 36 neovascular diseases 36 invasive candidiasis 36 PR interval prolongation 36 K ras mutations 36 neuroendocrine tumors 36 allogeneic stem cell 36 gastrointestinal stromal tumor 36 prenatal diagnosis 36 K ras mutation 36 trastuzumab Herceptin 36 node dissection 36 Neck Cancers 36 Mitomycin C 36 breast endometrial 36 lung transplantation 36 ovarian hyperstimulation syndrome OHSS 36 MYLOTARG 36 ventricular dysfunction 36 Oncology Drug 36 Randomized clinical trials 36 Gleevec resistant 36 malignant gliomas 36 DMARD therapy 36 malignant neoplasm 36 spokeswoman Cheri Russum 36 metastatic GIST 36 Acute Radiation Syndrome 36 cervical lymph node 36 Mark Willenbring 36 rediagnosed 36 skin sparing mastectomy 36 ischemic cardiac 36 colorectal cancer CRC 36 treatment regimens 36 demonstrated antitumor activity 36 immune suppressing 36 presurgery 36 severe Primary IGFD 36 anaplastic astrocytoma 36 PCNSL 36 immunological diseases 36 XL# SAR# 36 Ovary removal 36 biochemical recurrence 36 PKCi 36 invasive coronary angiography 36 Severe VOD 36 lung nodule 36 inhaled glucocorticoids 36 unfavorable cytogenetics 36 myelomas 36 temozolomide Temodar 36 temporal lobectomy 36 Cytoxan 36 Tasigna prolongs 36 incomplete revascularization 36 lymph node enlargement 36 CHOP chemotherapy 36 lung metastasis 36 BRAF V#E mutation 36 TAXOTERE ® 36 pre malignant lesions 36 antitumor effect 36 Behcet uveitis 36 chronic noncancer pain 36 Her2 positive 36 diffuse intrinsic pontine glioma 36 steroid refractory GvHD 36 relapsed refractory aggressive 36 postoperative morbidity 36 hormonal therapies 36 symptomatic hyponatremia 36 gastrointestinal bleed 36 LVNC 36 Advanced Melanoma 36 prognostically 36 Prognostic factors 36 postoperative pathology 36 SBRT 36 Autoimmune diseases 36 lymphadenectomy 36 fibrocystic disease 36 INVEGA ® SUSTENNA TM 36 detecting colorectal cancer 36 indolent lymphoma 36 clinically detectable 36 castration resistant hormone refractory 36 Cytarabine 36 Inflammatory diseases 35 SERCA2a 35 hepatic lesions 35 pegfilgrastim 35 hepatic metastases 35 acid suppressing 35 surgical resection 35 IV malignant melanoma 35 decompressive surgery 35 Genetic predisposition 35 Parkinson disease multiple sclerosis 35 detecting precancerous 35 Dr. Tommaso Falcone 35 recurrent glioma 35 metastatic osteosarcoma 35 gastrointestinal mucositis 35 BEACOPP 35 hemodynamically stable 35 feature Schofer 35 Dr. Maria Neira 35 Charlie Gilks 35 metastatic melanoma 35 HER2 negative 35 Malignant Glioma 35 lymphocytic leukemia 35 Dr. Karl Mettinger 35 recurrent Hodgkin 35 axillary lymph node dissection 35 metastatic RCC 35 micro calcifications 35 clinically heterogeneous 35 carcinoid tumor 35 EGFR mutation 35 documented unresectable 35 bronchopulmonary dysplasia BPD 35 hormonal therapy 35 bony metastases 35 paclitaxel Taxol ® 35 reversible coma 35 cotrimoxazole prophylaxis 35 acute diverticulitis 35 atherosclerotic renal artery stenosis 35 multivessel coronary artery 35 atrial fibrillation AFib 35 HQK 35 diagnostic mammogram 35 homozygous familial hypercholesterolemia 35 cintredekin besudotox 35 Basal cell 35 Mantle Cell Lymphoma 35 secondary amenorrhea 35 infliximab Remicade 35 chemopreventive agents 35 pathogenetic mechanisms 35 genomewide association studies 35 chronic HBV 35 embryonal rhabdomyosarcoma 35 Tarvacin Anti Cancer 35 bone scintigraphy 35 Glioblastoma multiforme GBM 35 prognostic 35 mutant KRAS 35 Fanconi syndrome 35 B7 H3 35 Zemiva TM 35 premalignant lesions 35 adalimumab Humira 35 underwent resection 35 non steroidals 35 NEUMUNE 35 macrovascular events 35 chronic granulomatous disease 35 pCR 35 CIPN 35 combinability 35 thymoma 35 mucinous 35 incontinence impotence 35 endometrial biopsy 35 gemifloxacin 35 resected pancreatic cancer 35 lymph node dissection 35 lymph node involvement 35 aortic root aneurysm 35 atrial tachyarrhythmias 35 parathyroidectomy 35 chemotheraphy 35 breat cancer 35 Insulin detemir 35 eosinophilic asthma 35 Therapeutic cloning 35 imatinib Gleevec 35 neurologic outcomes 35 gastric carcinoma 35 nonhormonal 35 SEGAs 35 pancreatic neuroendocrine tumor 35 Achilles tendon ruptures 35 neoplastic diseases 35 Panzem R 35 grade gliomas 35 FluCide 35 neuro muscular diseases 35 familial pancreatic cancer 35 pre cancerous lesion 35 cystic fibrosis chronic pancreatitis 35 bone marrow biopsy 35 sentinel nodes 35 esophageal candidiasis 35 maximally tolerated lipid lowering 35 Peritoneal Mesothelioma 35 metastatic malignant 35 CYT# potent vascular disrupting 35 tissue perfusion 35 autoimmune indications 35 haematologic malignancies 35 MELD score 35 hormone deprivation 35 hepatectomy 35 venous thromboembolic disease 35 anaplastic astrocytoma AA 35 Myelodysplastic syndrome 35 bone marrow suppression 35 neurologic deficits 35 Combivir Kivexa 35 curative surgical resection 34 brain tumor glioblastoma multiforme 34 Vectical TM Ointment 34 intravascular hemolysis 34 Squamous Cell Carcinoma 34 medullary thyroid cancer 34 urothelial carcinoma 34 anthracyclines 34 Toxicities 34 coronary CTA 34 induce remission 34 Radiofrequency ablation 34 Prenatal diagnosis 34 kidney pancreas transplant 34 bleak prognosis 34 clinically insignificant 34 microsphere therapy 34 spontaneous bacterial peritonitis 34 molar pregnancy 34 chemotherapeutic 34 Mofenson 34 Takotsubo cardiomyopathy 34 Maximo Pacheco 34 unruptured aneurysm 34 tyrosine kinase inhibitors TKIs 34 gastrointestinal stromal tumors GIST 34 EGFR tyrosine kinase inhibitors 34 pancreatic colon 34 opportunistic fungal infections 34 TELINTRA 34 radiographic findings 34 glioblastomas 34 radioiodine therapy 34 Metastatic 34 diagnose coronary artery 34 Immunotherapeutic 34 anticholinergic agents 34 carcinoid tumors 34 cutaneous lupus 34 ischemic vascular 34 anthracycline taxane 34 candidemia 34 prenatally diagnosed 34 steroid refractory 34 bladder tumors 34 histological subtypes 34 immuno suppressive 34 coronary angiogram 34 MADRID Spain Seve Ballesteros 34 Acute Myelogenous Leukemia 34 islet transplants 34 tonsil cancer 34 gastroenterology neurology 34 cardiac allograft vasculopathy 34 mTOR inhibitors 34 colo rectal 34 immune reconstitution 34 obstructed bile duct 34 Buerger Disease 34 Louise Van Diepen 34 doxorubicin HCl 34 diffuse gastric 34 Robert Pestronk 34 completely resected 34 periodic checkups 34 tissue plasminogen activator tPA 34 cervical lymph nodes 34 neuroprotective therapies 34 commercializes oncology 34 lowering blood glucose 34 Tyrima